These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24044567)

  • 1. Cathepsin D as an indicator of clinical outcome in early breast carcinoma during the first 3 years of follow-up.
    Markićević M; Kanjer K; Mandušić V; Buta M; Nešković-Konstantinović Z; Nikolić-Vukosavljević D
    Biomark Med; 2013 Oct; 7(5):747-58. PubMed ID: 24044567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosol cathepsin D in Thai women with breast cancer.
    Chearskul S; Bhothisuwan K; Tunsuphasiri V; Churinthrapun M; Keyanond V; Ornrheabroi S
    J Med Assoc Thai; 1996 Oct; 79(10):654-60. PubMed ID: 8997001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
    Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
    Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
    Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
    J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
    Bussen S; Rempen A; Caffier H
    Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic significance of cathepsin D in primary breast cancer].
    Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Schaeffer HJ; Stützer H; Bolte A
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):545-51. PubMed ID: 8001750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.
    Foekens JA; Look MP; Bolt-de Vries J; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Jan; 79(2):300-7. PubMed ID: 9888472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence.
    Ardavanis A; Scorilas A; Loukeri A; Gerakini F; Pissakas G; Missitzis I; Apostolikas N; Yiotis I
    Anticancer Res; 1998; 18(4B):2885-90. PubMed ID: 9713481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the tumor associated proteases cathepsin D (CATH D) and urokinase-type plasminogen activator (uPA) in cytosols of human breast cancer patients.
    Liebert A; Quietzsch D; Beier L
    Anticancer Res; 1999; 19(4A):2571-6. PubMed ID: 10470197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.
    Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H
    Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer.
    Ardavanis A; Scorilas A; Amanatidou A; Gerakini F; Missitzis I; Garoufali A; Pissakas G; Pateras C; Apostolikas N; Rigatos G; Yiotis I
    Anticancer Res; 1997; 17(2B):1405-9. PubMed ID: 9137506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic markers in node-negative breast cancer: a prospective study.
    Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
    Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays.
    Kute TE; Shao ZM; Sugg NK; Long RT; Russell GB; Case LD
    Cancer Res; 1992 Oct; 52(19):5198-203. PubMed ID: 1394123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics.
    Hähnel R; Harvey J; Robbins P; Sterrett G
    Anticancer Res; 1993; 13(6A):2131-5. PubMed ID: 8297125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
    Göhring UJ; Ingenhorst A; Crombach G; Scharl A
    Pathologe; 1993 Dec; 14(6):313-7. PubMed ID: 8121884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
    Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
    Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin D and prognosis in breast cancer.
    Tandon AK; Clark GM; Chamness GC; Chirgwin JM; McGuire WL
    N Engl J Med; 1990 Feb; 322(5):297-302. PubMed ID: 2296271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
    Todorovic-Rakovic N; Neskovic-Konstantinovic Z
    J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
    Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
    Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.